ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1181
    Gains in Cardiovascular Risk Knowledge Through Web Based Educational Intervention for Rheumatoid Arthritis Patients
  • Abstract Number: 1402
    Galectin-3 Decreases the Activity of 4-1BB by Facilitating Its Decoy Surface Binding in Rheumatoid Arthritis
  • Abstract Number: 1779
    Gap in Contraceptive Education to Females with Rheumatic Disease on Teratogenic Medications
  • Abstract Number: 0975
    Gasdermin D Modulates Murine Lupus and Its Associated Organ Damage
  • Abstract Number: 0267
    Gastrointestinal Disease in SLE: Does It Indicate a Worse Prognosis?
  • Abstract Number: 0821
    Gender and Discontinuation of Biologic DMARDs in Patients with Rheumatoid Arthritis: Data from the Mexican Biologics Registry
  • Abstract Number: 0876
    Gender Differences in Baseline Clinical Characteristics Among Patients with Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis: Data from 3 Randomized Ixekizumab Controlled Trials
  • Abstract Number: 1703
    Gender Equity in Academic Rheumatology – Is There a Gender Gap at European Rheumatology Congresses?
  • Abstract Number: 0034
    Gene Expression Signatures in C-Reactive Protein High and Low Rheumatoid Arthritis
  • Abstract Number: 1580
    Generalized Immune Activation in Structures Related to PMR or GCA on PET/CT Assessment Does Not Occur in Immune Checkpoint Inhibitor-Treated Patients Who Do Not Go on to Develop Rheumatic Immune-Related Adverse Events
  • Abstract Number: 0301
    Genetic Associations and Polygenic Risk Assessment in Incomplete Lupus Erythematosus
  • Abstract Number: 1862
    Genetic Influences on Occurrence of Axial Spondyloarthritis (axSpA) in First-degree Relatives During a Prospective Study Lasting 35 Years
  • Abstract Number: 0494
    Genetic-epigenetic Interaction and the Relationship Between DNA Methylation Patterns and Disease Activity in a Longitudinal Cohort of Lupus Patients
  • Abstract Number: 1669
    Genetics of Age at Diagnosis in Systemic Lupus Erythematosus
  • Abstract Number: 0982
    Genetics of Avascular Necrosis in Children and Adults with Systemic Lupus Erythematosus
  • Abstract Number: 1954
    Genome-wide Association Study of Sjögren’s Syndrome Identifies Ten New Risk Loci
  • Abstract Number: 0283
    Genome-wide DNA Methylation Analysis in Lupus Keratinocytes Identifies Differential Methylation of Genes That Regulate Apoptosis
  • Abstract Number: 0661
    Genomic Regions Jointly Associated with eGFR and Serum Urate: Implications for Shared Genetic Etiology of Hyperuricemia and Chronic Kidney Disease
  • Abstract Number: 0500
    Genomic, Phenomic, Proteomic Predictors of Psoriatic Arthritis
  • Abstract Number: 2037
    Geographic Distribution and Environmental Triggers of Systemic Sclerosis in Massachusetts
  • Abstract Number: 0086
    Geographic Distribution of Eosinophilic Fasciitis Cases in Massachusetts and Associated Environmental Triggers
  • Abstract Number: 0043
    Geographical Disparity in Rheumatoid Arthritis Disease Burden Independent of Race/Ethnicity
  • Abstract Number: 0005
    Geographical Variations in COVID-19 Perceptions and Patient Management: A National Survey of Rheumatologists
  • Abstract Number: 0238
    Gestational Desire and Certolizumab Pegol in Patients with Chronic Inflammatory Rheumatic Disease. Preliminary Results of the GESTAMAD Cohort
  • Abstract Number: 1257
    Gestational Diabetes Mellitus in Pregnant Women with Systemic Lupus Erythematosus
  • Abstract Number: 1932
    Giant Cell Arteritis – the Relationship Between the Extensiveness of Vasculitis and the Clinical Presentation
  • Abstract Number: 1077
    Glucagon-like Peptide-1 Receptor Agonist Suppresses Muscle Inflammation and Muscle Fiber Death, and Ameliorates Muscle Weakness in Experimental Polymyositis
  • Abstract Number: 1224
    Glucocorticoid Reduction in Different Profiles of Patients with Rheumatoid Arthritis and Treatment with Sarilumab
  • Abstract Number: 0129
    Glucocorticoid-Induced Osteoporosis in Patients with Chronic Inflammatory Rheumatic Diseases: A Multivariate Linear Regression Analysis Identifying Factors Affecting Bone Mineral Density
  • Abstract Number: 0109
    Glucocorticoid-Induced Osteoporosis: Are We Practicing Prevention?
  • Abstract Number: 1682
    Goal-Setting Improves Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus
  • Abstract Number: 0578
    Going Digital Due to COVID 19 Crisis: A Rapid Reorganisation of Medication Clinics
  • Abstract Number: 0657
    Gout and Heart Failure in the US
  • Abstract Number: 0681
    Gout and Serum Urate Levels Are Associated with Lumbar Spine Monosodium Urate Deposition and Chronic Low Back Pain: A Dual-Energy CT Study
  • Abstract Number: 1573
    Gout as an Immune-Related Adverse Event from Immune Checkpoint Inhibitors
  • Abstract Number: 0600
    Gout Increases Length of Stay in Patients Hospitalized for Heart Failure Exacerbation
  • Abstract Number: 0673
    Gout Is an Independent Risk Factor for Undergoing an Amputation Procedure
  • Abstract Number: 0667
    Gout Management Beyond Prescription Writing: The Role of the Pharmacist
  • Abstract Number: 0853
    Gradual Glucocorticoid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus
  • Abstract Number: 0259
    Guillain-Barré Syndrome in Systemic Lupus Erythematosus – Results of a Nationwide Analysis
  • Abstract Number: 0888
    Guselkumab Efficacy and Safety in TNF-Inhibitor-Experienced and TNF-Inhibitor-Naïve Patients with Active PsA: 1-Year Results of a Phase 3, Randomized, Controlled Study
  • Abstract Number: 0908
    Guselkumab Efficacy in Adult Patients with Active Psoriatic Arthritis by Baseline Demographic and Disease Characteristics: Pooled Results of Two Phase 3, Randomized, Placebo-Controlled Studies
  • Abstract Number: 0332
    Guselkumab Improved Work Productivity and Daily Activity in Patients with Psoriatic Arthritis: Results from a Phase 3 Trial
  • Abstract Number: 0367
    Guselkumab Induces Sustained Reduction in Acute Phase Proteins and Th17 Effector Cytokines in Active Psoriatic Arthritis in Two Phase-3 Clinical Trials (DISCOVER-1 and DISCOVER-2)
  • Abstract Number: 1349
    Guselkumab Provides Domain-Specific and Comprehensive Efficacy as Assessed Using Composite Endpoints in Patients with Active Psoriatic Arthritis
  • Abstract Number: 0370
    Guselkumab-Treated Patients Achieved Clinically Meaningful Improvement in Systemic Symptoms as Measured with PROMIS Instrument: Results from Phase-3 Psoriatic Arthritis Trial DISCOVER 1
  • Abstract Number: 1344
    Guselkumab, an IL-23 Inhibitor That Specifically Binds to the IL23p19-Subunit, for Active Psoriatic Arthritis: One Year Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Patients Who Were Biologic-Naïve or TNFα Inhibitor-Experienced
  • Abstract Number: 1310
    Gut Microbiome Changes Are Different Between Ankylosing Spondylitis and Inflammatory Bowel Disease, and Correlate with Disease Activity in Both Diseases
  • Abstract Number: 1971
    Gut Microbiome Transplantation from MRL/MpJ Mice Prevents Post-Traumatic Osteoarthritis in C57BL6/J Mice
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences